S

Samil Pharmaceutical Co Ltd
KRX:000520

Watchlist Manager
Samil Pharmaceutical Co Ltd
KRX:000520
Watchlist
Price: 10 380 KRW 0.29%
Market Cap: 225.1B KRW

Intrinsic Value

The intrinsic value of one Samil Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 10 380 KRW, Samil Pharmaceutical Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Samil Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Samil Pharmaceutical Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Samil Pharmaceutical Co Ltd looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether Samil Pharmaceutical Co Ltd usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Samil Pharmaceutical Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Samil Pharmaceutical Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Samil Pharmaceutical Co Ltd.

Explain Valuation
Compare Samil Pharmaceutical Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Samil Pharmaceutical Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Samil Pharmaceutical Co Ltd

Current Assets 87.7B
Cash & Short-Term Investments 2.8B
Receivables 36.1B
Other Current Assets 48.9B
Non-Current Assets 287.8B
Long-Term Investments 37.3B
PP&E 238.6B
Intangibles 4.8B
Other Non-Current Assets 7.2B
Current Liabilities 138.9B
Accounts Payable 17B
Accrued Liabilities 7.2B
Short-Term Debt 56B
Other Current Liabilities 58.7B
Non-Current Liabilities 87.4B
Long-Term Debt 60.1B
Other Non-Current Liabilities 27.3B
Efficiency

Free Cash Flow Analysis
Samil Pharmaceutical Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Samil Pharmaceutical Co Ltd

Revenue
217.2B KRW
Cost of Revenue
-138B KRW
Gross Profit
79.2B KRW
Operating Expenses
-90.8B KRW
Operating Income
-11.6B KRW
Other Expenses
-8.2B KRW
Net Income
-19.8B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Samil Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Healthy Gross Margin
Sustainable 3Y Average Gross Margin
Declining Gross Margin
Declining Net Margin
hidden
Profitability
Score

Samil Pharmaceutical Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Samil Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
hidden
Solvency
Score

Samil Pharmaceutical Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Samil Pharmaceutical Co Ltd

Wall Street analysts forecast Samil Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Samil Pharmaceutical Co Ltd is 13 260 KRW with a low forecast of 13 130 KRW and a high forecast of 13 650 KRW.

Lowest
Price Target
13 130 KRW
26% Upside
Average
Price Target
13 260 KRW
28% Upside
Highest
Price Target
13 650 KRW
32% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Samil Pharmaceutical Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Samil Pharmaceutical Co Ltd stock?

The intrinsic value of one Samil Pharmaceutical Co Ltd stock under the Base Case scenario is hidden KRW.

Is Samil Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared to the current market price of 10 380 KRW, Samil Pharmaceutical Co Ltd is hidden .

Back to Top